Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Trading Statement

28 Jan 2026 07:00

RNS Number : 6290Q
FDM Group (Holdings) plc
28 January 2026
 

28 January 2026

FDM GROUP (HOLDINGS) PLC ("FDM GROUP", "FDM" or "THE GROUP")

YEAR END TRADING UPDATE

FDM Group, a global professional services provider with a focus on Information Technology, today provides a trading update for the year to 31 December 2025, ahead of its full year results, which will be released on 18 March 2026.

Group Trading in the Period and Closing Balance Sheet

The Board anticipates that the Group's financial performance for the year to 31 December 2025 will be within the range of market expectations1.

2025 was, much like the preceding two years, a challenging trading year. The Board has continued its focus on aligning resource levels to match client demand, as far as practicable, tailored to the specifics of each geographical operating market. As highlighted in the Group's trading update in November 2025, this included a cautious increase in the volume of consultants in training in the UK, North America and Australia in response to a degree of pick up in activity levels in some of our key operating geographies in the latter part of the year; the Group delivered 828 training completions during 2025 (2024: 877 training completions).

Revenue for the year to 31 December 2025 is expected to be £178 million, down 31% (30% on a constant currency basis) in comparison to the prior year (2024: £258 million).

The Group ended the year with 2,003 Consultants placed with clients (2024: 2,578). The UK closed with 910 Consultants deployed (2024: 1,056); North America closed with 500 Consultants deployed (2024: 742); APAC closed with 469 Consultants deployed (2024: 524); and EMEA closed with 124 Consultants deployed (2023: 256).

The Group's balance sheet remains robust with closing cash balances of £35 million (2024: £41 million). The Group has no debt.

Outlook

Rod Flavell, Group CEO, commented:

"We have been encouraged that the uptick in activity levels which we saw in the last four months of 2025 shows signs of continuing into early 2026. Clearly, the economic and political backdrops remain uncertain and market conditions remain subdued, but there are signs that an appreciable number of our clients have appetite for investment, with some of them already initiating activity.

Your Board will continue to align resources with demand, be prudent with investment and mindful of continuing market uncertainties. We are focussed on enabling FDM's return to growth as soon as our markets allow."

1Company-compiled range of analysts' expectations for FY25 Adjusted Profit Before Tax is £13.5m to £14.4m.

For further information please contact:

FDM Group

Rod Flavell - Chief Executive Officer

Mike McLaren - Chief Financial Officer

Mark Heather - Group Governance Director & Company Secretary

 

 

Tel: +44 (0)20 3056 8240

 

Financial PR

Nick Oborne

Tel: +44 (0)7850 127526

 

Forward-Looking Statements

This trading update may contain statements which constitute 'forward-looking statements'. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. Subject to any requirement under the Disclosure Guidance and Transparency Rules or other applicable legislation, regulation or rules, the Group does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Neither shareholders nor prospective shareholders should place undue reliance on forward-looking statements, which speak only as of the date of this Trading Update.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRMBTMTBTTLF
Date   Source Headline
12th Mar 20255:25 pmRNSDirector/PDMR Shareholding
4th Mar 20254:34 pmRNSHolding(s) in Company
10th Feb 20257:00 amRNSHolding(s) in Company
6th Feb 20255:59 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:26 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
30th Jan 202512:42 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNSTrading Statement
9th Jan 20255:33 pmRNSDirector/PDMR Shareholding
4th Dec 20244:49 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20247:00 amRNSTrading Update
7th Nov 20243:58 pmRNSDirector/PDMR Shareholding
1st Nov 20247:47 amRNSTotal Voting Rights
9th Oct 20245:30 pmRNSDirector/PDMR Shareholding
1st Oct 202411:30 amRNSTotal Voting Rights
11th Sep 20245:16 pmRNSDirector/PDMR Shareholding
11th Sep 20244:50 pmRNSNotification of Transactions of Directors & PDMRs
2nd Sep 20247:00 amRNSTotal Voting Rights
13th Aug 202412:00 pmRNSDirector/PDMR Shareholding
1st Aug 20241:33 pmRNSPDMR Shareholding
1st Aug 20241:30 pmRNSPDMR Shareholding
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:04 pmRNSAppointment of Joint Corporate Broker
31st Jul 20247:00 amRNSHalf-year Report
11th Jul 20242:58 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSTotal Voting Rights
13th Jun 202411:45 amRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:36 pmRNSDirector/PDMR Shareholding
29th May 20249:37 amRNSDirector/PDMR Shareholding
15th May 20244:13 pmRNSDirectorate Change
14th May 20244:34 pmRNSResult of AGM
14th May 20247:00 amRNSAGM Statement
10th May 20241:48 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
29th Apr 20248:00 amRNSDirector Declaration
12th Apr 20247:14 amRNSDirector/PDMR Shareholding
9th Apr 202412:00 pmRNSNotice of 2024 Annual General Meeting
2nd Apr 20249:00 amRNSTotal Voting Rights
20th Mar 20248:20 amRNSPreliminary Results
8th Mar 202412:24 pmRNSDirector/PDMR Shareholding
1st Mar 202410:39 amRNSTotal Voting Rights
13th Feb 20241:05 pmRNSDirector Declaration
7th Feb 20243:18 pmRNSDirector/PDMR Shareholding
5th Feb 20242:02 pmRNSHolding(s) in Company
1st Feb 20249:57 amRNSTotal Voting Rights
31st Jan 20245:00 pmRNSDirector Declaration
31st Jan 20247:00 amRNSYear End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.